Our expertise

Deep integration of biomedical science and machine learning applied to drug discovery and translational research.

Mature man with glasses and a trimmed beard smiling confidently, standing in warm natural light against a modern backdrop.

a word from our ceo

“Succesful AI systems require understanding of complex biology, careful engineering and ease at deployment at industrial scale”

Amalio Telenti, Trail's Founder & CEO

Muli-Omics Systems Biology

Integrating transcriptomics and perturbation screens

Integration of transcriptomics, single-cell data, and functional screens to identify gene programs and disease-relevant pathways.

Host Genetics of Disease Biology

Human variation and infection outcomes

Analysis of how human genetic variation influences susceptibility to infection, immune response, and disease progression.

Host Genetics of Disease Biology

Human variation and infection outcomes

Analysis of how human genetic variation influences susceptibility to infection, immune response, and disease progression.

Host Genetics of Disease Biology

Human variation and infection outcomes

Analysis of how human genetic variation influences susceptibility to infection, immune response, and disease progression.

Muli-Omics Systems Biology

Integrating transcriptomics and perturbation screens

Integration of transcriptomics, single-cell data, and functional screens to identify gene programs and disease-relevant pathways.

Host Genetics of Disease Biology

Human variation and infection outcomes

Analysis of how human genetic variation influences susceptibility to infection, immune response, and disease progression.

Host Genetics of Disease Biology

Human variation and infection outcomes

Analysis of how human genetic variation influences susceptibility to infection, immune response, and disease progression.

Host Genetics of Disease Biology

Human variation and infection outcomes

Analysis of how human genetic variation influences susceptibility to infection, immune response, and disease progression.

Research Institutes

Infrastructure and analytical systems supporting large collaborative projects and multimodal biological datasets.
Exploration of Compounds in Chemical and Functional Space

Identification of bioactive metabolites that modulate macrophage differentiation (M1/M2) through high-throughput imaging screens. The project integrates metabolite fraction screening with a curated library of ~1,300 compounds to match phenotypic signatures and identify active molecules.

Metadata-driven data platforms for experimental programs

Multi-omics analysis pipelines

Integration of transcriptomics, proteomics, and imaging data

Compound annotation

From chemical and metabolite screens to macrophage biology — decoding polarization

Research Institutes

Infrastructure and analytical systems supporting large collaborative projects and multimodal biological datasets.
Exploration of Compounds in Chemical and Functional Space

Identification of bioactive metabolites that modulate macrophage differentiation (M1/M2) through high-throughput imaging screens. The project integrates metabolite fraction screening with a curated library of ~1,300 compounds to match phenotypic signatures and identify active molecules.

Metadata-driven data platforms for experimental programs

Multi-omics analysis pipelines

Integration of transcriptomics, proteomics, and imaging data

Compound annotation

From chemical and metabolite screens to macrophage biology — decoding polarization

Research Institutes

Infrastructure and analytical systems supporting large collaborative projects and multimodal biological datasets.
Exploration of Compounds in Chemical and Functional Space

Identification of bioactive metabolites that modulate macrophage differentiation (M1/M2) through high-throughput imaging screens. The project integrates metabolite fraction screening with a curated library of ~1,300 compounds to match phenotypic signatures and identify active molecules.

Metadata-driven data platforms for experimental programs

Multi-omics analysis pipelines

Integration of transcriptomics, proteomics, and imaging data

Compound annotation

From chemical and metabolite screens to macrophage biology — decoding polarization

Public Health

Computational platforms and AI systems supporting therapeutic discovery.
AI Enabled Cures Frontier (AIEC), Gates Foundation

Development of AI-enabled approaches to drug discovery for curative interventions targeting virally induced chronic diseases, with current programs focused on HPV

Collaborative AI systems

Funtional genomics and perturbation screens

CRISPR screen data integration and analysis

Interfaces for exploration and collaborative analysis

AI-accelerated novel therapies for global health challenges

Public Health

Computational platforms and AI systems supporting therapeutic discovery.
AI Enabled Cures Frontier (AIEC), Gates Foundation

Development of AI-enabled approaches to drug discovery for curative interventions targeting virally induced chronic diseases, with current programs focused on HPV

Collaborative AI systems

Funtional genomics and perturbation screens

CRISPR screen data integration and analysis

Interfaces for exploration and collaborative analysis

AI-accelerated novel therapies for global health challenges

Public Health

Computational platforms and AI systems supporting therapeutic discovery.
AI Enabled Cures Frontier (AIEC), Gates Foundation

Development of AI-enabled approaches to drug discovery for curative interventions targeting virally induced chronic diseases, with current programs focused on HPV

Collaborative AI systems

Funtional genomics and perturbation screens

CRISPR screen data integration and analysis

Interfaces for exploration and collaborative analysis

AI-accelerated novel therapies for global health challenges

Biotechnology

Computational systems supporting target identification, mechanism-of-action studies, and molecular design.
Drug Discovery

Drug Discovery integrates biological databases, pathway analysis, and LLM-enabled literature synthesis to assist scientists in generating and evaluating hypotheses across complex biological datasets.

Target discovery from perturbation screens and omics data

Mechanism-of-action inference

LLM-assisted scientific interpretation

AI-assisted literature and knowledge synthesist

Biotechnology

Computational systems supporting target identification, mechanism-of-action studies, and molecular design.
Drug Discovery

Drug Discovery integrates biological databases, pathway analysis, and LLM-enabled literature synthesis to assist scientists in generating and evaluating hypotheses across complex biological datasets.

Target discovery from perturbation screens and omics data

Mechanism-of-action inference

LLM-assisted scientific interpretation

AI-assisted literature and knowledge synthesist

Biotechnology

Computational systems supporting target identification, mechanism-of-action studies, and molecular design.
Drug Discovery

Drug Discovery integrates biological databases, pathway analysis, and LLM-enabled literature synthesis to assist scientists in generating and evaluating hypotheses across complex biological datasets.

Target discovery from perturbation screens and omics data

Mechanism-of-action inference

LLM-assisted scientific interpretation

AI-assisted literature and knowledge synthesist

Big ambitions?

We'd love to hear them

We'd love to hear them

From question to hypothesis, together.

Big ambitions?

Big ambitions?

We'd love to hear them

Big ambitions?

We'd love to hear them

We'd love to hear them

From question to hypothesis, together.

Trail Biomed sàrl. Batterie 543 1969 Suen (St-Martin), Valais, Switzerland

© 2026 Trail Biomed. All rights reserved

Trail Biomed sàrl. Batterie 543 1969 Suen (St-Martin), Valais, Switzerland

© 2026 Trail Biomed. All rights reserved

Trail Biomed sàrl. Batterie 543 1969 Suen (St-Martin), Valais, Switzerland

© 2026 Trail Biomed. All rights reserved